The Lipoprint® Lipoprotein Subfractions Testing System analyzes all lipoprotein fractions and subfractions in fasting serum or plasma.
The Lipoprint LDL subfraction test is an in vitro test device for new emerging risk factors.
Understanding and analyzing the test results are the first steps to acheiving a more focused patient diagnosis.
The Lipoprint HDL test is a convenient, non-denaturing, linear polyacrylamide gel electrophoresis method.
Lipoprint provides the clinician with personalized lipoprotein athergenic subfractions data for individual patient CVD risk assessment.
Our in-house testing services is designed specifically for researchers with a limited number of samples to run.
Everything you need is in the box!
You’re one step closer to helping at risk patients benefit from primary prevention treatment.
Speak with one of our customer representatives about Lipoprint or request product literature.